Log In
Print this Print this

HIV gene therapy, MazF gene therapy

  Manage Alerts
Collapse Summary General Information
Company Takara Bio Inc.
DescriptionRibonuclease MazF based gene therapy
Molecular Target
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector
Latest Stage of DevelopmentPhase I
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV/AIDS
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today